Inhalable cannabis & CBD

London, United Kingdom

Short Summary

hapac® is a unique patent pending system for vaporising medical cannabis and CBD. It is simple, sustainable & has the potential to be the lowest-cost cannabis product in the market due to its high-speed automated production and low variable costs.

Overview

Target
€1,700,000
Minimum
€22,000
Investment Raised
€170,000
Previous Rounds €680,000
Stage Achieving Sales
Investor Role Any

Highlights

  • Partnership with Italian market leader in cannabis & CBD.
  • First hapac® production line up and running in Italy.
  • Already raised £150k - EIS approved.
  • Patent pending; designs & trademarks registered in EU & North America.
  • Medical cannabis: pharmacokinetic trials planned at 2 UK university hosp.s
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
10% raised

Fertility Innovations Ltd

location_on South West, United Kingdom

FIL has invented & patented the worlds only direct male infertility treatment. Non-invasive, deliverable in primary healthcare facilities, 85%+ effective with sales potential £1.3bn+ pa, set to disrupt & transform the £10bn pa infertility market.

€ 560,000

Target

€ 5,600

Min per Investor

0% raised

The Moment Movement

location_on London, United Kingdom

We have created a physical product to reduce stress and support digital detox and proven we can reach a valuable market need by selling 1350 on a 30 day Kickstarter campaign. We have manufacturing lined up and require capital for stock.

€ 170,000

Target

€ 11,000

Min per Investor

0% raised

Asaya Cosmeceuticals Ltd.

location_on London, United Kingdom

Innovative medical cosmeceutical skincare company with patent at international phase, to successfully treat melasma, hyperpigmentation and hypertrophic and atrophic post-operative scars. All claims medically validated. Business plan available.

€ 110,000

Target

€ 11,000

Min per Investor

load one similar proposal